Together, these data revealed that SINV-WT and SINV-GM-CSF had tumor-killing abilities in Hep3B cell tumor models, suggesting that SINV vectors have great potential as innovative therapeutic agents for treating human hepatocellular carcinomas. The gene discussed is CSF2; the disease is hepatocellular carcinoma.